Raymond James Maintains Outperform on Merit Medical Systems, Raises Price Target to $89
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford has maintained an Outperform rating on Merit Medical Systems (NASDAQ:MMSI) and increased the price target from $84 to $89.
January 30, 2024 | 10:19 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Raymond James analyst Jayson Bedford has reaffirmed an Outperform rating on Merit Medical Systems and raised the price target to $89.
The increase in price target by Raymond James reflects a positive outlook on Merit Medical Systems, which could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100